PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)
Status:
Recruiting
Trial end date:
2025-05-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether applying povidone iodine (PVI) to the noses of
patients undergoing lower extremity (leg, ankle, or foot) orthopedic fixation procedures of
high-energy lower extremity fractures (HELEF) will decrease the patients' risk of surgical
site infections (SSI), particularly those caused by Staphylococcus aureus.
Phase:
Phase 4
Details
Lead Sponsor:
Loreen Herwaldt
Collaborators:
Centers for Disease Control and Prevention Emory University Indiana University PDI Healthcare University of Texas University of Utah Washington University School of Medicine